A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
Hajime Asahina, Kentaro Tanaka, Satoshi Morita, Makoto Maemondo, Masahiro Seike, Isamu Okamoto, Satoshi Oizumi, Hiroshi Kagamu, Kazuhisa Takahashi, Toshiaki Kikuchi, Takeshi Isobe, Kenji Sugio, Kunihiko Kobayashi
Topics & Concepts
PemetrexedOsimertinibMedicineCarboplatinInternal medicineLung cancerGefitinibOncologyT790MPhases of clinical researchEpidermal growth factor receptorChemotherapyCisplatinCancerErlotinibLung Cancer Treatments and MutationsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Research Studies